expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
agreement 312.0 1.9 0.6 0.0 (311.4) (99.8) Gain on disposals of investments in subsidiaries 314.8 1.9 458.6 3.2 143.7 45.7 Other income 262.0 1.6 465.3 3.3 203.3 77.6 Total Revenues 16,637.8 100.0 14,122.1
พฤศจิกายน 2559 ที่ประชมุคณะกรรมการบริษัทฯ ครัง้ที่ 9/2559 ได้มีมตอินมุตัิท าสญัญา “Business Administration Agreement” และจ่ายคา่ธรรมเนียมให้กบับริษัท อิออน ไฟแนนเชียล เซอร์วิส จ ากดั (“AFS”) เป็นจ านวน
ทําสญัญา “Business Administration Agreement” และจ่ายคา่ธรรมเนียมให้กบับริษัท อิออน ไฟแนนเชียล เซอร์วิส จํากดั (“AFS”) มลค่ารวมของรายการู : มลค่าู บริษัท เยน บาท AEONTS 255,955,000 78,273,599 ACSS 11,477,000
result of repayment of long-term loans from financial institutions, and increase in liability under hire purchase agreement amount of Baht 3.41 million. 3. Shareholder equity as at June 30, 2017 amount of
approval of the acquisition from the Comapany’s Board of Director No. 5/2017 held on 31 October 2017. The Share Purchase Agreement will be effective after Board of Director’s approval. 2) Related Contract
long-term loans which was due and this long-term loan agreement will be due in 2018. Liabilities under finance lease agreements, net of current portion decreased by 12.8 MB or representing decreased of
hire purchase agreement amount of Baht 4.07 million. 3. Shareholder equity as at September 30, 2017 amount of Baht 648.33 million decrease from December 31, 2016 by Baht 30.08 or 4.43% , since the
been commenced and the total values of receivables under the concession agreement and intangible assets as ended September 30, 2017 were Baht 10.58 million and Baht 4.31 million, respectively. Slib
under hire purchase agreement amount of Baht 3.72 million. 3. Shareholder equity as at, December 31, 2017 amount of Baht 668.28 million decrease from December 31, 2016 by Baht 10.13 or 1.49% , since the